Raloxifene

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4441 publications

Post-Marketing Ocular Adverse Events Associated with Tamoxifen and Raloxifene: A Population-Based Pharmacovigilance Study.

Post-Marketing Ocular Adverse Events Associated with Tamoxifen and Raloxifene: A Population-Based Pharmacovigilance Study.

Journal: Retina (Philadelphia, Pa.)
Published: July 09, 2026

Raloxifene inhibits the proliferation of pediatric acute myeloid leukemia by targeting the ANP32B gene and regulating C-MYC expression.

Raloxifene inhibits the proliferation of pediatric acute myeloid leukemia by targeting the ANP32B gene and regulating C-MYC expression.

Journal: Hematology (Amsterdam, Netherlands)
Published: June 29, 2026

Using Deep Learning Models of Gene Regulation to Guide Drug Prioritization.

Using Deep Learning Models of Gene Regulation to Guide Drug Prioritization.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 15, 2026

Raloxifene suppresses growth and promotes intrinsic apoptotic signaling in C6 glioma cells.

Raloxifene suppresses growth and promotes intrinsic apoptotic signaling in C6 glioma cells.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 01, 2026

Histoprotective and antiproliferative effects of Raloxifene treatment during prostate carcinogenesis in rats.

Histoprotective and antiproliferative effects of Raloxifene treatment during prostate carcinogenesis in rats.

Journal: Toxicology and applied pharmacology
Published: May 31, 2026

Structural and energetic modulation of the raloxifene-STAT3 complex by metformin and cisplatin: implications for disrupting STAT3 signaling.

Structural and energetic modulation of the raloxifene-STAT3 complex by metformin and cisplatin: implications for disrupting STAT3 signaling.

Journal: Journal of biomolecular structure & dynamics
Published: May 30, 2026

Validating raloxifene-mediated restoration of DNMT-TET epigenetic balance in breast and lung cancer.

Validating raloxifene-mediated restoration of DNMT-TET epigenetic balance in breast and lung cancer.

Journal: Cancer treatment and research communications
Published: May 21, 2026

Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stress.

Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stress.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 11, 2026

Estrogen signaling and ferroptosis in intervertebral disc degeneration: A proposed mechanistic framework and its evidence gaps.

Estrogen signaling and ferroptosis in intervertebral disc degeneration: A proposed mechanistic framework and its evidence gaps.

Journal: Tissue & cell
Published: May 05, 2026

Multi-omics analysis identifies CD48 and ITIH5 as potential diagnostic biomarkers and therapeutic targets for metabolic disorders associated with obesity.

Multi-omics analysis identifies CD48 and ITIH5 as potential diagnostic biomarkers and therapeutic targets for metabolic disorders associated with obesity.

Journal: Gene
Published: April 26, 2026

Multi-step in silico study of potential estrogen receptor alpha modulators: Integrating hierarchical virtual screening, pharmacokinetics, MM-GBSA, molecular dynamics, and DFT studies.

Multi-step in silico study of potential estrogen receptor alpha modulators: Integrating hierarchical virtual screening, pharmacokinetics, MM-GBSA, molecular dynamics, and DFT studies.

Journal: Journal of molecular graphics & modelling
Published: April 15, 2026

Correction to "HSD17B7 Counters Bone Loss in Estrogen Deficiency via Estrogen Receptor Stabilization and Mediates the Effect of Raloxifene".

Correction to "HSD17B7 Counters Bone Loss in Estrogen Deficiency via Estrogen Receptor Stabilization and Mediates the Effect of Raloxifene".

Journal: MedComm
Published: April 14, 2026
Showing 1-12 of 4,441

Last Updated: 09/26/2026